Loading...
  • cardiac-resynch
  • Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. (nih.gov)
  • We tested the hypothesis that prophylactic cardiac-resynchronization therapy in the form of biventricular stimulation with a pacemaker with or without a defibrillator would reduce the risk of death and hospitalization among patients with advanced chronic heart failure and intraventricular conduction delays. (nih.gov)
  • In patients with advanced heart failure and a prolonged QRS interval, cardiac-resynchronization therapy decreases the combined risk of death from any cause or first hospitalization and, when combined with an implantable defibrillator, significantly reduces mortality. (nih.gov)
  • heart
  • Improved patient education and ongoing psychological support will help people cope with the psychological distress of having an implanted defibrillator, according to a scientific statement from the American Heart Association. (medicalxpress.com)
  • Medical
  • Medical researchers recently concluded the first systematic test in which they weighed one such promising factor--an electrical characteristic called T-wave alternans--for deciding who should get a defibrillator. (thefreelibrary.com)
  • The intervention group will receive the PtDA, which provides a lay summary that outlines the facts, risks, benefits (including probabilities), specific to the option of an implantable defibrillator or the option of medical management to prepare them for consultation with the physician. (clinicaltrials.gov)
  • risk
  • A pacemaker reduced the risk of the secondary end point of death from any cause by 24 percent (P=0.059), and a pacemaker-defibrillator reduced the risk by 36 percent (P=0.003). (nih.gov)